- Home
- LARK vs ACHV Comparison
LARK vs ACHV Comparison
Compare LARK & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LARK
- ACHV
- Stock Information
- Founded
- LARK 1885
- ACHV N/A
- Country
- LARK United States
- ACHV United States
- Employees
- LARK N/A
- ACHV N/A
- Industry
- LARK Major Banks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LARK Finance
- ACHV Health Care
- Exchange
- LARK Nasdaq
- ACHV Nasdaq
- Market Cap
- LARK 150.1M
- ACHV 167.6M
- IPO Year
- LARK N/A
- ACHV N/A
- Fundamental
- Price
- LARK $26.50
- ACHV $4.47
- Analyst Decision
- LARK
- ACHV Strong Buy
- Analyst Count
- LARK 0
- ACHV 1
- Target Price
- LARK N/A
- ACHV $12.00
- AVG Volume (30 Days)
- LARK 6.8K
- ACHV 1.4M
- Earning Date
- LARK 10-29-2025
- ACHV 11-06-2025
- Dividend Yield
- LARK 3.09%
- ACHV N/A
- EPS Growth
- LARK 38.73
- ACHV N/A
- EPS
- LARK 2.98
- ACHV N/A
- Revenue
- LARK $64,367,999.00
- ACHV N/A
- Revenue This Year
- LARK N/A
- ACHV N/A
- Revenue Next Year
- LARK N/A
- ACHV N/A
- P/E Ratio
- LARK $9.06
- ACHV N/A
- Revenue Growth
- LARK 12.95
- ACHV N/A
- 52 Week Low
- LARK $20.75
- ACHV $1.84
- 52 Week High
- LARK $31.04
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- LARK 68.78
- ACHV 49.33
- Support Level
- LARK $25.43
- ACHV $4.26
- Resistance Level
- LARK $26.15
- ACHV $4.90
- Average True Range (ATR)
- LARK 0.47
- ACHV 0.35
- MACD
- LARK 0.18
- ACHV -0.11
- Stochastic Oscillator
- LARK 99.48
- ACHV 10.34
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.